NCT04488497Completed
Cardiovascular Risk Assessment for Patients With Rheumatoid Arthritis Arthritis:
Optimization of Hyperlipidemia Management Among Patients With Rheumatoid Arthritis: A Patient-centered Intervention Development
Source: ClinicalTrials.gov · Last updated 24 Oct 2025
Brief summary (registry, in English)
One of the greatest success stories in rheumatology - the achievement of rheumatoid arthritis (RA) remission - is tempered by the fact that individuals with RA are dramatically under evaluated and under treated to reduce the risk for heart attacks and strokes. This project will build the foundation for an intervention that will test the hypothesis that the patient-centered intervention tailored to patients with RA to improve hyperlipidemia screening and treatment, thereby decreasing the risk for heart attacks and strokes. The aims of this proposal are: Aim 1: To identify patient and physician barriers to lower the risk for heart attacks and strokes in patients with RA. Aim 2: To develop an intervention designed to optimize lipid screening and management in RA patients. This will consist of patient education and a decision support program to facilitate screening for hyperlipidemia (high cholesterol level) or initiation of medications to lower cholesterol (primary outcome) and self-efficacy (level of confidence in performing a task) in taking medications to lower cholesterol secondary outcome). Aim 3: To pilot test the efficacy and feasibility of intervention developed in Aim 2. The investigators will apply methods related to clinical trials to test the feasibility of the newly developed intervention.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 101 (actual)
- First submitted
- 22 Jul 2020
- Start date
- Jan 2021
- Primary completion date
- Nov 2024
- Lead sponsor
- Weill Medical College of Cornell University
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT04488497
What you commit to
- Study type: Interventional
- Participants enrolled: 101
- From Jan 2021 to the primary completion date, Nov 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- No known history of diabetes
- No known history of CVD defined by:
- Open heart surgery
- Coronary angioplasty
- History of heart failure
- History of heart attack or stroke
Age
- Younger than age 40 or older than age 75
Other
- Do not have rheumatoid arthritis
- Taking a statin
Who the study is looking for
- Have RA
- Age between 40 and 75 years (inclusive)
- Provide a date of their next appointment with their rheumatologist or other physician on their care team
- Willing to work with a peer coach
- Speaks English
- Have a phone
- Has access to the internet
- Resides or lives in the US
Age in the registry: 40 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Weill Cornell Medicine Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.